AANA Journal Course 3 Update for nurse anesthetists Aortic stenosis: A review
|
|
- Julia Wells
- 7 years ago
- Views:
Transcription
1 AANA Journal Course 3 Update for nurse anesthetists Aortic stenosis: A review 6 CE Credits* David Phillips, CRNA, MSN Wake Forest, North Carolina 2005 Student Writing Contest Honorable Mention The prevalence of aortic stenosis has been increasing in recent decades, and nurse anesthetists are more likely to encounter this problem as the population ages. Fortunately, the widespread use of echocardiography has expanded our understanding of valvular heart disease. The purpose of this course is to evaluate the current literature regarding aortic stenosis with a focus on anesthetic management. The 2 most common causes of aortic stenosis are calcific tricuspid disease and congenital bicuspid valves. An inflammatory, atherosclerotic disease process also has been identified in aortic stenosis. Patients with aortic stenosis are at high risk for perioperative cardiac complications. Anesthetic management often includes invasive hemodynamic monitoring and carefully tailored anesthetic techniques. Key words: Anesthesia, anesthetic management, aortic stenosis, noncardiac surgery, risk. Objectives At the conclusion of this course, the reader should be able to: 1. List the most common causes of aortic stenosis. 2. Describe the pathophysiology of aortic stenosis. 3. Differentiate mild, moderate, and severe aortic stenosis. 4. Explain the significance of aortic stenosis in patients undergoing noncardiac surgery. 5. Discuss the anesthetic management of patients with aortic stenosis. Introduction Few cardiovascular diseases present more of a challenge to anesthesia professionals than aortic stenosis (AS). People who live with this disease often have little or no cardiac reserve, and they may not tolerate the stress response associated with surgery. Likewise, most anesthetic techniques produce hemodynamic changes that can be disastrous in the presence of significant AS. It is estimated that 2% of elderly Americans have AS. 1 The prevalence has risen in recent decades because of a growing elderly population and improved diagnostic techniques. The number of patients with a diagnosis of AS and the number of aortic valve replacement (AVR) surgeries has climbed steadily since 1990 (Figure 1). 2 In 2002, there were 56,000 AVR surgeries, constituting 72% of all valve replacements that year. 2 These trends suggest that anesthesia providers are increasingly likely to care for these patients during cardiac and noncardiac surgery. Figure 1. Increasing prevalence of aortic stenosis (AS) Diagnoses (in thousands ) Diagnoses Year AVR The number of patients discharged from hospitals with a diagnosis of nonrheumatic AS and the number of patients undergoing aortic valve replacement (AVR). Data from the National Center for Health Statistics AVR (in thousands ) *AANA Journal Course No. 26: The American Association of Nurse Anesthetists is accredited as a provider of continuing education in nursing by the American Nurses Credentialing Center Commission on Accreditation. The AANA Journal course will consist of 6 successive articles, each with objectives for the reader and sources for additional reading. At the conclusion of the 6-part series, a final examination will be printed in the AANA Journal. Successful completion will yield the participant 6 CE credits (6 contact hours), code number: 28327, expiration date: July 31, AANA Journal/August 2006/Vol. 74, No
2 Causes Rheumatic heart disease was the primary cause of AS in the United States before The widespread use of penicillin and improved diagnostic criteria have led to a decline in the prevalence of rheumatic AS. 3 During the same period, calcification of a tricuspid aortic valve emerged as a major cause of AS. 3 This condition is associated with advanced age and is more prevalent now simply because people are living longer. A pathologic study of surgically removed valves demonstrated that the 2 most common cases of AS in the United States are calcification of tricuspid valves and congenital bicuspid valves (Figure 2). 3 An estimated 1% to 2% of the general population is born with a bicuspid aortic valve. 4 Most people with bicuspid aortic valves develop calcific changes by late middle age that require valve replacement by the seventh decade of life. 5 Pathogenesis Calcific tricuspid AS traditionally was thought to result from wear and tear of the valve that progressively worsened with age, thus the label degenerative or senile AS. It now is recognized that calcific AS involves an inflammatory, atherosclerotic process similar to that in coronary artery disease. 4 The risk factors for calcific AS are remarkably similar to those of atherosclerotic disease and include increased age, male gender, height, smoking, hypertension, diabetes mellitus, high low-density lipoprotein levels, and low high-density lipoprotein levels. 1,6 Indeed, people with AS have a high prevalence of coronary artery disease and peripheral arterial disease. 7,8 Several series report similar immunohistological changes in the lesions of atherosclerotic disease and calcific AS. 9,10 The initial injury in AS results from mechanical stress that disrupts the valvular endothelial basement membrane. This disruption promotes lipid accumulation, infiltration of macrophages and T lymphocytes, and, finally, calcification. Therefore, calcific AS is not merely a degenerative process but rather an active and potentially modifiable disease process. Bicuspid valves have 1 less cusp to share the workload and are prone to stenosis because of the greater mechanical stress. After the initial injury, the same inflammatory changes that take place in tricuspid stenosis are seen in bicuspid valves. 11 However, calcification of a bicuspid valve occurs more rapidly and requires surgical replacement at an average of a decade earlier than in tricuspid stenosis. 5 Rheumatic heart disease remains a significant cause of AS in the United States. This disease is initiated by a pharyngeal infection with group A streptococci. Susceptible individuals seem to develop an autoimmune Figure 2. Causes of aortic stenosis* Calcific tricuspid 51% * Data from Dare et al. 3 Other 4% Rheumatic 9% Calcific bicuspid 36% process that results in fibrosis of the cusps, fusion of the commissures, and calcification. Rheumatic AS is almost always seen with mitral stenosis. 4 Pathophysiology All of the common causes of AS eventually result in calcification, regardless of the initial cause. Calcification of the cusps on the aortic side of the valve (Figure 3) impedes opening of the valve during systole. A reduced valve area produces an obstruction to left ventricular outflow. To maintain a normal stroke volume, the left ventricle compensates with concentric hypertrophy, a process in which the myocardium thickens without enlargement of the ventricular cavity. The myocardium hypertrophies over many years as the obstruction becomes more severe. 4 The thick myocardium produces sufficiently high left ventricular pressures when contracting to force blood past the valvular obstruction. A pressure gradient results between the left ventricle and the ascending aorta during systole and frequently is reported on echocardiogram and catheterization reports. The ventricular hypertrophy maintains normal wall stress despite the increased pressure load on the left ventricle. As a result, contractility is preserved until late in the disease process when the obstruction becomes so severe that the pressure load overwhelms the ability of the ventricles to compensate. The left ventricle is the end organ affected in AS. 4 Diastolic dysfunction can occur earlier in the disease process. The left ventricle becomes less compliant. Ventricular filling is impaired due to poor diastolic relaxation and becomes increasingly reliant on 310 AANA Journal/August 2006/Vol. 74, No. 4
3 Figure 3. Calcific aortic stenosis Table 1. Aortic stenosis severity* Severity Valve area (cm 2 ) Normal 3-4 Mild >1.5 Moderate Severe <1.0 * Data from Bonow et al. 15 A tricuspid aortic valve with large calcium nodules (black arrow), unfused commissures (white arrow), and a small valve area. left atrial contraction to fill. Left ventricular end-diastolic pressures often are elevated. Left atrial enlargement and pulmonary hypertension can result. 4 In a person with asymptomatic AS, cardiac output can increase in response to stresses through an increase in heart rate but not through an increase in stroke volume. When the heart rate accelerates, there is a decreased systolic period during which stroke volume is maintained by an increase in the pressure gradient, an increased flow rate through the aortic valve, and a slight increase in valve area. However, when the stenosis becomes severe, the leaflets become more rigid and stroke volume cannot be maintained when the heart rate increases. The person becomes symptomatic with activity or stress. Heart failure is the end result. 4 Clinical manifestations The classic triad of symptoms for AS are dyspnea, angina, and syncope. Exertional dyspnea is the most common initial symptom and is a sign of impending left ventricular failure. Angina is seen even in the absence of coexisting coronary artery disease. Coronary flow is inadequate to meet the increased demands of the hypertrophied left ventricle. Exertional syncope is a symptom specific to AS and helps rule out other valvular disorders. In a prospective study that looked at 397 patients (95% were symptomatic), the incidence of symptoms were as follows: dyspnea, 63%; angina, 51%; syncope, 42%; and other, 13%. 12 Diagnosis Aortic stenosis usually is detected during physical examination by the presence of a grade 3 or 4 systolic murmur that is heard over the right second intercostal space. Other specific findings include a late peaking of the murmur and a significant delay and decrease in the carotid upstroke. 13 These are useful screening tools in asymptomatic patients; however, echocardiography is the gold standard for confirming the diagnosis and determining the severity of stenosis. Echocardiography is noninvasive and cost-effective compared with cardiac catheterization, and it provides superior information on the morphologic features and motion of the aortic valve. 14 The aortic valve area and the aortic pressure gradient are the 2 most commonly used determinants of stenosis severity. These parameters can be measured with echocardiography and cardiac catheterization. Severe AS is categorized as a valve area less than 1 cm 2 (Table 1) and a pressure gradient of more than 50 mm Hg. 15 Most patients with a valve area less than 0.5 cm 2 have severe hemodynamic alterations and can have pressure gradients of more than 100 mm Hg. 12 Disease course This disease begins with a latent period that extends over several decades. Outcome remains good in the absence of symptoms, with few cardiac deaths reported. 16 The hemodynamic progression of the disease is rather linear, with the valve area decreasing 0.12 cm 2 per year and the pressure gradient increasing 7 mm Hg per year. 17 Once the valve area is reduced to about one fourth of its original size, more rapid hemodynamic alterations occur. 18 Noticeable symptoms do not usually occur until severe stenosis is present. The average valve area at symptom onset is 0.93 cm 2, and the average pressure gradient is 49 mm Hg 17 ; however, there is wide individual variation. The presence of symptoms is the best indicator of outcome. The onset of symptoms is associated with a high risk for sudden cardiac death. 16 A study of patients who refused AVR revealed that mor- AANA Journal/August 2006/Vol. 74, No
4 tality was 57% at 3 years after the onset of symptoms. 19 The average age at which patients become symptomatic depends on the cause: rheumatic disease, 39 years; bicuspid disease, 48 years; and calcific tricuspid disease, 66 years. 20 Treatment There are no definitive medical treatments for AS other than antibiotic prophylaxis to prevent infective endocarditis and limitations on physical activity. 15 However, there is hope for new medical therapies because calcific aortic stenosis now is believed to involve an active inflammatory atherosclerotic process. For example, recent retrospective trials demonstrated a slowing of disease progression in patients receiving statin therapy. 21,22 Randomized clinical trials are currently evaluating this therapy. Asymptomatic patients are evaluated with echocardiography every 1 to 5 years. Once symptoms appear, the recommended treatment for AS is valve replacement. 15 The mortality rate for AVR is 4% and, when combined with coronary revascularization, 6%. 23 After the obstruction is removed, there is symptomatic improvement and a regression in left ventricular hypertrophy. 4 Ventricular wall mass returns to normal after 8 years. 21 Long-term survival after the procedure is comparable to age-related norms. 24 Percutaneous balloon aortic valvuloplasy is a less invasive procedure that is clearly inferior to valve replacement in adult patients. Still, it can modestly increase valve area for a few months and is recommended for some patients who are not candidates for AVR and need temporary improvement. 15 The search for other less invasive procedures has persisted. In 2002, the first human case of a percutaneous aortic valve replacement was reported. 25 This experimental procedure is performed under local anesthesia and mild sedation. This new technology is being proposed as a possible treatment for patients with severe AS whose risk for surgery is too high due to comorbidities. Research in this area is ongoing. Aortic stenosis and noncardiac surgery The current guideline is for patients with severe or symptomatic AS to undergo AVR before elective noncardiac surgery. 26 This is not always possible because the patient may be a poor candidate for AVR, the patient may refuse AVR, or the procedure is too urgent. If noncardiac surgery must be performed, some patients can benefit from preoperative balloon valvuloplasty. 26 Several studies have looked at the risk associated with AS and noncardiac surgery (Table 2). The classic report by Goldman et al 27 was the first to report an increased risk of cardiac complications. This was followed by a few trials in the 1980s and 1990s that suggested a more modest risk The authors attributed these results to more aggressive monitoring and therapy. However, these studies had small samples, and the study by O Keefe et al 28 consisted mostly of minor procedures with sedation and local anesthesia. More recently, Rohde et al 31 found that patients with a pressure gradient or more than 40 mm Hg have 6.8 times the risk for cardiac complications, and Kertai et al 32 Table 2. Reported risk for patients with aortic stenosis undergoing noncardiac surgery* No. of Outcomes Reference Year Design cases measured Reported risk Kertai et al Retrospective 108 Nonfatal MI, death Relative risk for gradient >25 after adjustment for clinical factors, 5.2 Rohde et al Prospective 67 Major cardiac events Relative risk for gradient >40 after adjustment for clinical factors, 6.8 Raymer and Yang Retrospective 55 Major cardiac events 5/55 had event; 2 MI, 2 CHF, 1 VF; same risk as control group Torsher et al Retrospective 22 Cardiac events, death 2/22 had event; 1 fatal MI, 1 noncardiac death O Keefe et al Retrospective 48 Perioperative complica- 1/48 had event, 1 VT tions Goldman et al Retrospective 23 Postoperative cardiac Relative risk, 3.2 events * MI indicates myocardial infarction; CHF, congestive heart failure; VF, ventricular fibrillation; and VT, ventricular tachycardia. This does not include 6 cases of hypotension included by the authors. 312 AANA Journal/August 2006/Vol. 74, No. 4
5 reported that patients with a gradient of more than 25 mm Hg have 5.2 times the risk. The recent studies confirm the early results by Goldman and colleagues. 27 Patients with AS are clearly at higher risk for developing cardiac complications, including myocardial infarction, heart failure, and ventricular arrhythmias. In the study by Rohde et al, 31 AS had the highest risk of all the echocardiographic variables studied, including mitral regurgitation. Finally, the report by Kertai et al 32 indicated that the degree of stenosis is proportional to the level of risk. Patients with a pressure gradient of 25 to 49 mm Hg had a 15% complication rate, whereas patients with a gradient of more than 50 mm Hg had a 30% complication rate. Anesthetic management The principles of anesthetic management for AS are similar for cardiac and noncardiac surgery. The preoperative assessment is focused on determining the severity of AS. Whenever possible, the patient should be evaluated before surgery by a cardiologist and have an echocardiogram. Routine auscultation of heart sounds for a loud systolic murmur can identify undiagnosed patients admitted for surgery. The level of suspicion is raised if there is a history of angina, dyspnea, syncope, rheumatic disease, or a known bicuspid valve. Patients with AS and bicuspid valves are considered at moderate risk for the development of bacterial endocarditis and should receive antibiotic prophylaxis according to the American Heart Association guidelines. 33 Light premedication with anxiolytics during the preoperative period can minimize the release of catecholamines in anxious patients. Intraoperative management is directed toward maintaining hemodynamic stability and cardiac output. Patients with AS usually are vasoconstricted before induction and easily become hypotensive with the administration of anesthesia. Hypotension should be treated aggressively with an alpha-adrenergic agonist such as phenylephrine to maintain coronary perfusion, which is dependent on diastolic pressure at the aortic root. 34 The ischemic cascade that follows hypotension is illustrated in Figure 4. The ideal heart rate ranges from 50 to 70 beats per minute. 35 Tachycardia can result in ischemia and also does not allow enough systolic time for flow across the stenotic aortic valve. Excessive bradycardia decreases cardiac output. Maintenance of sinus rhythm is important to maintain the atrial contribution to ventricular filling. Supraventricular tachycardias and atrial fibrillation should be treated immediately with synchronized cardioversion. 35 External defibrillators are used for prompt conversion of ventricular fibrillation because Figure 4. Potential downward hemodynamic spiral Blood pressure Preload SVR Anesthetics Coronary perfusion Cardiovascular collapse Ventricular dysfunction SVR indicates systemic vascular resistance. Myocardial ischemia chest compressions are not effective in pushing blood through a stenotic valve. 4 Fluid status should be optimized so the noncompliant left ventricle can maintain stroke volume. There is a low threshold for the placement of invasive hemodynamic monitors in patients with AS. Arterial catheters commonly are used for beat-to-beat blood pressure monitoring. Pulmonary artery catheters are useful for evaluating fluid status and cardiac output. Left-sided filling pressures normally are elevated in AS because of a noncompliant ventricle, and volume status is easily underestimated. 34 Central venous catheters are poor indicators of fluid status in AS. 34 Transesophageal echocardiography is a useful direct measure of preload and contractility, but the probe cannot be inserted until after the critical induction period. 35 A 5-lead electrocardiogram is recommended for detection of ischemia and arrhythmias. Close monitoring should continue into the postoperative period, especially if the surgery involves significant fluid shifts. 4 Anesthetic technique There is little research supporting one anesthetic technique over another for AS. The literature regarding this issue consists primarily of case reports. Some authors of anesthesia texts recommend general anesthesia over regional anesthesia because it allows greater control over blood pressure. 36,37 If general anesthesia is chosen, the sympathetic response to direct laryngoscopy should be attenuated to prevent ischemia. An opioid-based technique produces minimal cardiovascular effects Any medication that causes significant myocardial depression, hypotension, tachycardia, bradycardia, or histamine release should be used cautiously. Volatile anesthetics are used in low concentrations to avoid myocardial AANA Journal/August 2006/Vol. 74, No
6 depression and nodal arrythmias. 34 Some authors consider severe AS to be a contraindication to spinal and epidural anesthesia. 36 The sympathectomy produced can result in rapid hypotension and deterioration in the patient s condition (see Figure 4). However, epidural anesthesia results in a more gradual decline in blood pressure and allows incremental titration of anesthetics. Epidural anesthetics have been used at some institutions for parturients with congenital AS. 38,39 A sample of other regional anesthetic techniques used safely in case reports includes intrathecal sufentanil for lithotripsy, 40 continuous spinal anesthesia for hip replacement, 41 and a combined lumbar plexus and sciatic nerve block for hip replacement. 42 Carefully planned regional techniques like these may be an option for select patients with AS. Summary Nurse anesthetists will encounter more patients with AS as the elderly population continues to grow. Patients with AS are at substantial risk for cardiac complications in the perioperative period. A coordinated effort is needed among surgeons, cardiologists, and anesthesia professionals to minimize the risk. Aggressive hemodynamic monitoring and gentle anesthetic techniques can provide the majority of these patients with favorable outcomes. REFERENCES 1. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol. 1997;29: National Center for Health Statistics. National Hospital Discharge Survey, Series 13. Hyattsville, Md: Centers for Disease Control and Prevention, Available at: Accessed April 13, Dare AJ, Veinot JP, Edwards WD, Tazelaar HD, Schaff HV. New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from Hum Pathol. 1993;24: Otto CM. Valvular Heart Disease. 2nd ed. Philadelphia, Pa: Saunders; Davies MJ, Treasure T, Parker DJ. Demographic characteristics of patients undergoing aortic valve replacement for stenosis: relation to valve morphology. Heart. 1996;75: Wilbert SA, Chul A, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol. 2001;88: Aronow WS, Ahn C, Kronzon I. Association of valvular aortic stenosis with symptomatic peripheral arterial disease in older persons. Am J Cardiol. 2001;88: Rapp AH, Hillis D, Lange RA, Cigarroa JE. Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris. Am J Cardiol. 2001;87: Otto CM, Kuusisto J, Reichenback DD, Gown AM, O Brien KD. Characterization of the early lesion of degenerative valvular aortic stenosis: histological and immunohistochemical studies. Circulation. 1994;90: Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol. 1994;23: Wallby L, Janerot-Sjoberg B, Steffensen T, Broqvist M. T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves. Heart. 2002;88: Lombard T, Selzer A. Valvular aortic stenosis: a clinical and hemodynamic profile of patients. Ann Intern Med. 1987;106: Munt B, Legget ME, Kraft CD, Miyake-Hull CY, Fujioka M, Otto CM. Physical examination in valvular aortic stenosis: correlation with stenosis severity and prediction of clinical outcome. Am Heart J. 1999;137: Popovic AD, Stewart WJ. Echocardiographic evaluation of valvular stenosis. Echocardiography. 2001;18: Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol. 1998:32: Kelly TA, Rothbart RM, Cooper M, Kaiser DL, Smucker, ML, Gibson RS. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol. 1988;61: Otto CM, Burwash IG, Legget ME, et al. A prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95: Carabello BA. Aortic stenosis. N Engl J Med. 2002;246: Chizner MA, Pearle DL, de Leon AC. The natural history of aortic stenosis in adults. Am Heart J. 1980;99: Horstkott D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. 1988;9(suppl E): Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation. 2001;104: Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol. 2001;88: Society of Thoracic Surgeons. STS National Database Fall 2000 Executive Summary. Chicago, Ill: Society of Thoracic Surgeons Available at: Accessed April 18, Monrad ES, Hess OM, Murakami T, Nonogi H, Corin WJ, Krayenbuehl HP. Time course of regression of left ventricular hypertrophy after aortic valve replacement. Circulation. 1988;77: Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106: Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2002; 105: Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977:297: O Keefe JH, Shub C, Rettke SR. Risk of surgical procedures in patients with aortic stenosis. Mayo Clin Proc. 1989;64: Torsher LC, Shub C, Rettke SR, Brown DL. Risk of patients with severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol. 1998;81: Raymer K, Yang H. Patients with aortic stenosis: cardiac complications in non-cardiac surgery. Can J Anaesth. 1998;45: Rohde LE, Polanczyk CA, Goldman L, Cook EF, Lee RT, Lee TH. Usefulness of transthoracic echocardiography as a tool for risk stratification of patients undergoing major noncardiac surgery. Am J Cardiol. 2001;87: Kertai MD, Bountioukos M, Boersma E, et al. Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med. 2004;116: AANA Journal/August 2006/Vol. 74, No. 4
7 33. Dajani AS, Taubert KA, Bolger WW, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA. 1997;277: de Villiers PA, Starr NJ. Anesthesia for the surgical management of valvular heart disease. In: Thys DM, Hillel Z, Schwartz AJ, eds. Cardiothoracic Anesthesiology. New York, NY: McGraw-Hill: 2001: Moore RA, Martin DE. Anesthetic management for the treatment of valvular heart disease. In: Hensley FA, Martin DE, Gravlee GP, eds. A Practical Approach to Cardiac Anesthesia. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2003: Morgan GE, Mikhail MS, Murray MJ. Clinical Anesthesiology. 3rd ed. New York, NY: McGraw-Hill; Dayton DB. Cardiovascular anatomy, physiology, and pathophysiology. In: Nagelhout JL, Zaglaniczny KL. Nurse Anesthesia. 2nd ed. Philadelphia, Pa: Saunders; 2001: Lao TT, Sermer M, MaGee L, Farine D, Colman JM. Congenital aortic stenosis and pregnancy: a reappraisal. Am J Obstet Gynecol. 1993;169: Brighouse D. Anaesthesia for caesarean section in patients with aortic stenosis: the case for regional anaesthesia. Anaesthesia. 1998;53: Eaton M. Intrathecal sufentanil analgesia for extracorporeal shock wave lithotripsy in three patients with aortic stenosis. Anesth Analg. 1998;86: Collard CD, Eappen S, Lynch EP, Concepcion M. Continuous spinal anesthesia with invasive monitoring for surgical repair of the hip in two patients with severe aortic stenosis. Anesth Analg. 1995;81: Ho AM, Karmakar MK. Combined paravertebral lumbar plexus and parasacral sciatic nerve block for reduction of hip fracture in a patient with severe aortic stenosis. Can J Anesth. 2002;49: AUTHOR David Phillips, CRNA, MSN, is a staff nurse anesthetist at Franklin Regional Medical Center, Louisburg, NC. He was a student at Duke University Nurse Anesthesia Program, Durham, NC, when this course was written. dwpcrna@yahoo.com ACKNOWLEDGMENT I thank all the nurse anesthetists and anesthesiologists at Durham Regional Hospital, Durham, NC, for sharing their wealth of knowledge in cardiac anesthesia. AANA Journal/August 2006/Vol. 74, No
Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery
Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery Srinivasan Rajagopal M.D. Assistant Professor Division of Cardiothoracic Anesthesia Objectives Describe the pathophysiology
More informationPerioperative Cardiac Evaluation
Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project
More informationCARDIAC RISKS OF NON CARDIAC SURGERY
CARDIAC RISKS OF NON CARDIAC SURGERY N E W S T U D I E S & N E W G U I D E L I N E S W. B. C A L H O U N, M D, F A C C 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management
More informationCardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg
Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate
More informationPre-Operative Cardiac Evaluation Kalpana Jain, MD
Pre-Operative Cardiac Evaluation Kalpana Jain, MD Cardiac evaluation is an integral part of pre-op evaluation. Perioperative cardiac events are common causes of mortality. Major cardiac complications associated
More informationHow To Understand What You Know
Heart Disorders Glossary ABG (Arterial Blood Gas) Test: A test that measures how much oxygen and carbon dioxide are in the blood. Anemia: A condition in which there are low levels of red blood cells in
More information5. Management of rheumatic heart disease
5. Management of rheumatic heart disease The fundamental goal in the long-term management of RHD is to prevent ARF recurrences, and therefore, prevent the progression of RHD, and in many cases allow for
More informationLow-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity
Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity Jean-Luc MONIN, MD, PhD Henri Mondor University Hospital Créteil, FRANCE Disclosures : None 77-year-old woman, mild dyspnea
More information2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.
DISCLOSURES I have no relevant financial relationships to disclose. Cardiac Evaluation of Potential Solid Organ Transplant Recipients Michele Hamilton, MD Director, Heart Failure Program Cedars Sinai Heart
More informationHEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise
WEEK 3 SUPPLEMENT HEART HEALTH A Beginner s Guide to Cardiovascular Disease HEART FAILURE Heart failure can be defined as the failing (insufficiency) of the heart as a mechanical pump due to either acute
More informationObjectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History
Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize
More informationPotential Causes of Sudden Cardiac Arrest in Children
Potential Causes of Sudden Cardiac Arrest in Children Project S.A.V.E. When sudden death occurs in children, adolescents and younger adults, heart abnormalities are likely causes. These conditions are
More informationAortic Valve Stenosis and CAD
EUROECHO 14, Copenhagen 2010 Aortic Valve Stenosis and CAD Aleksandar N. Neskovic Clinical Hospital Center Zemun Belgrade University School of Medicine Aortic Stenosis and CAD Important facts Links AS/CAD
More informationCardiovascular diseases. pathology
Cardiovascular diseases pathology Atherosclerosis Vascular diseases A disease that results in arterial wall thickens as a result of build- up of fatty materials such cholesterol, resulting in acute and
More informationECG may be indicated for patients with cardiovascular risk factors
eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,
More informationSection Four: Pulmonary Artery Waveform Interpretation
Section Four: Pulmonary Artery Waveform Interpretation All hemodynamic pressures and waveforms are generated by pressure changes in the heart caused by myocardial contraction (systole) and relaxation/filling
More informationManaging Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular
Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular Mitral Regurgitation Anatomy Mechanisms of MR Presentation Evaluation Management Repair Replace Clip
More informationExchange solutes and water with cells of the body
Chapter 8 Heart and Blood Vessels Three Types of Blood Vessels Transport Blood Arteries Carry blood away from the heart Transport blood under high pressure Capillaries Exchange solutes and water with cells
More informationTreating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC
Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG
More informationDr Richard Telford. Introduction
Dr Richard Telford Valvular Heart Disease 1. You visit a patient who is due to have an orthopaedic procedure. He tells you he gets occasional chest pain and shortness of breath on exertion. You notice
More informationPerioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing
Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis Michael A. Blazing Outline The coming crush A practical approach to clinical risk assessment Classic approach to
More informationINTRODUCTION TO EECP THERAPY
INTRODUCTION TO EECP THERAPY is an FDA cleared, Medicare approved, non-invasive medical therapy for the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and
More informationAuscultation of the Heart
Review of Clinical Signs uscultation of the Heart Series Editor: Bernard Karnath, MD Bernard Karnath, MD William Thornton, MD uscultation of the heart can provide clues to the diagnosis of many cardiac
More informationCoronary Artery Disease leading cause of morbidity & mortality in industrialised nations.
INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.
More informationHISTORY. Questions: 1. What diagnosis is suggested by this history? 2. How do you explain her symptoms during pregnancy?
HISTORY 33-year-old woman. CHIEF COMPLAINT: months duration. Dyspnea, fatigue and nocturnal wheezing of six PRESENT ILLNESS: At ages 5 and 9, she had migratory arthritis. At age 29, in the third trimester
More informationMedical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
More informationBASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY
BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology
More informationHow To Treat Heart Valve Disease
The Valve Clinic at Baptist Health Madisonville The Valve Clinic at Baptist Health Madisonville Welcome to the Baptist Health Madisonville Valve Clinic at the Jack L. Hamman Heart & Vascular Center. We
More information4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts
Cardiac Rehabilitation: From the other side of the glass door No disclosures, no conflicts Charles X. Kim, MD, FACC, ABVM Objectives 1. Illustrate common CV benefits of CV rehab in real world practice.
More informationType II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease
Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University
More informationSteven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators
Long-Term Outcomes Using a Self- Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery: Two-Year Results From the CoreValve US Pivotal Trial Steven J. Yakubov,
More informationAtrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated
More informationEducational Goals & Objectives
Educational Goals & Objectives The Cardiology rotation will provide the resident with an understanding of cardiovascular physiology and its broad systemic manifestations. The resident will have the opportunity
More informationProvider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code 78451-78454 78469)
Provider Checklist-Outpatient Imaging Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code 78451-78454 78469) Medical Review Note: Per InterQual, if any of the following are present,
More informationSpecific Basic Standards for Osteopathic Fellowship Training in Cardiology
Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011
More informationNoncardiac surgery in patients with aortic stenosis
Page 1 of 16 Official reprint from UpToDate www.uptodate.com 2010 UpToDate Noncardiac surgery in patients with aortic stenosis Authors Michelle V Conde, MD Joe M Moody, Jr, MD Section Editor Catherine
More informationAutomatic External Defibrillators
Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationReal-Time 3-Dimensional Transesophageal Echocardiography in the Evaluation of Post-Operative Mitral Annuloplasty Ring and Prosthetic Valve Dehiscence
Journal of the American College of Cardiology Vol. 53, No. 17, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.12.059
More informationOsama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015
STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 PROJECT TITLE: Analysis of ECG Exercise Stress Testing and Framingham Risk Score in Chest Pain Patients PRIMARY SUPERVISOR NAME: Dr. Edward Tan DEPARTMENT:
More informationAnaesthesia and Heart Failure
Anaesthesia and Heart Failure Andrew Baldock, Specialist Registrar, Southampton University Hospitals NHS Trust E mail: ajbaldock@doctors.org.uk Self-assessment The following true/false questions may be
More informationCommon Surgical Procedures in the Elderly
Common Surgical Procedures in the Elderly From hip and knee replacements to cataract and heart surgery, America s elderly undergo 20% of all surgical procedures. For a group that comprises only 13% of
More informationCardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy
Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy File name: Cardiac Rehabilitation (Outpatient Phase II) File code: UM.REHAB.04 Origination: 08/1994 Last Review: 08/2011 Next Review:
More informationCTA OF THE EXTRACORONARY HEART
CTA OF THE EXTRACORONARY HEART Charles White MD Director of Thoracic Imaging Department of Radiology University of Maryland NO DISCLOSURES CWHITE@UMM.EDU CARDIAC CASE DISTRIBUTION Coronary CTA 30% ED chest
More informationHYPERTROPHIC CARDIOMYOPATHY
HYPERTROPHIC CARDIOMYOPATHY Most often diagnosed during infancy or adolescence, hypertrophic cardiomyopathy (HCM) is the second most common form of heart muscle disease, is usually genetically transmitted,
More informationNAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3
1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications
More informationTAVR: A New Treatment Option for Aortic Stenosis. Alexis Auger, MSN, NP-BC
TAVR: A New Treatment Option for Aortic Stenosis Alexis Auger, MSN, NP-BC 22nd Annual Northeast Regional Nurse Practitioner Conference May 6-8, 2015 DISCLOSURES There has been no commercial support or
More informationRACE I Rapid Assessment by Cardiac Echo. Intensive Care Training Program Radboud University Medical Centre NIjmegen
RACE I Rapid Assessment by Cardiac Echo Intensive Care Training Program Radboud University Medical Centre NIjmegen RACE Goal-directed study with specific questions Excludes Doppler ultrasound Perform 50
More informationDiagnostic and Therapeutic Procedures
Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,
More informationCARDIOLOGY ROTATION GOALS AND OBJECTIVES
CARDIOLOGY ROTATION GOALS AND OBJECTIVES PGY-1 Core Medicine Rotation The trainee will have the opportunity to develop clinical skills, the ability to analyze patients problems, and make treatment plans
More informationMain Effect of Screening for Coronary Artery Disease Using CT
Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,
More informationResuscitation in congenital heart disease. Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto
Resuscitation in congenital heart disease Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto Evolution of Congenital Heart Disease Extraordinary success: Overall
More informationPractical class 3 THE HEART
Practical class 3 THE HEART OBJECTIVES By the time you have completed this assignment and any necessary further reading or study you should be able to:- 1. Describe the fibrous pericardium and serous pericardium,
More informationClinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013. Reference: NHSCB/A09/PS/b
Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013 Reference: NHS Commissioning Board Clinical Commissioning Policy Statement: Percutaneous
More informationPalpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust
Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia
More informationRATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent
More informationNote: The left and right sides of the heart must pump exactly the same volume of blood when averaged over a period of time
page 1 HEART AS A PUMP A. Functional Anatomy of the Heart 1. Two pumps, arranged in series a. right heart: receives blood from the systemic circulation (via the great veins and vena cava) and pumps blood
More informationUW MEDICINE PATIENT EDUCATION. Aortic Stenosis. What is heart valve disease? What is aortic stenosis?
UW MEDICINE PATIENT EDUCATION Aortic Stenosis Causes, symptoms, diagnosis, and treatment This handout describes aortic stenosis, a narrowing of the aortic valve in your heart. It also explains how this
More informationCommon types of congenital heart defects
Common types of congenital heart defects Congenital heart defects are abnormalities that develop before birth. They can occur in the heart's chambers, valves or blood vessels. A baby may be born with only
More informationDiagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses
Diagnosis Code Crosswalk : to 402.01 Hypertensive heart disease, malignant, with heart failure 402.11 Hypertensive heart disease, benign, with heart failure 402.91 Hypertensive heart disease, unspecified,
More informationAANA Journal Course 4
AANA Journal Course 4 Update for nurse anesthetists Preoperative cardiac evaluation *6 CE Credits Bob Halliburton, CRNA, DNSc Saint Louis, Missouri Donald Bell, CRNA, DNSc John Preston, CRNA, DNSc Knoxville,
More information1 Congestive Heart Failure & its Pharmacological Management
Harvard-MIT Division of Health Sciences and Technology HST.151: Principles of Pharmocology Instructor: Prof. Keith Baker 1 Congestive Heart Failure & its Pharmacological Management Keith Baker, M.D., Ph.D.
More informationDynamic Auscultation of Heart Sounds and Murmurs. Acknowledgement. Disclosures Real or Potential Conflicts of Interest
Dynamic Auscultation of Heart Sounds and Murmurs W. Lane Edwards, Jr., MSN, ARNP, ANP Hospitalist Group of Southwest Florida Affiliate Professor of Nursing, University of Alaska at Anchorage Acknowledgement
More informationANAESTHESIA FOR THE PATIENT WITH PULMONARY HYPERTENSION ANAESTHESIA TUTORIAL OF THE WEEK 228
ANAESTHESIA FOR THE PATIENT WITH PULMONARY HYPERTENSION ANAESTHESIA TUTORIAL OF THE WEEK 228 20 TH JUNE 2011 Dr Sarah Thomas, Senior Anaesthetic Registrar Royal Hobart Hospital Correspondence to sarah.thomas@dhhs.tas.gov.au
More informationDistance Learning Program Anatomy of the Human Heart/Pig Heart Dissection Middle School/ High School
Distance Learning Program Anatomy of the Human Heart/Pig Heart Dissection Middle School/ High School This guide is for middle and high school students participating in AIMS Anatomy of the Human Heart and
More informationManagement of Pacing Wires After Cardiac Surgery
Management of Pacing Wires After Cardiac Surgery David E. Lizotte, Jr. PA C, MPAS, FAPACVS President, Association of Physician Assistants in Cardiovascular Surgery Conflicts: None Indications 2008 Journal
More informationChristopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona
Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Areas to be covered Historical, current, and future treatments for various cardiovascular disease: Atherosclerosis (Coronary
More informationTABLE 1 Clinical Classification of AF. New onset AF (first detected) Paroxysmal (<7 days, mostly < 24 hours)
Clinical Practice Guidelines for the Management of Patients With Atrial Fibrillation Deborah Ritchie RN, MN, Robert S Sheldon MD, PhD Cardiovascular Research Group, University of Calgary, Alberta Partly
More informationANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head
ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY Dr. Mahesh Vakamudi Professor and Head Department of Anesthesiology, Critical Care and Pain Medicine Sri Ramachandra University INTRODUCTION
More informationThe P Wave: Indicator of Atrial Enlargement
Marquette University e-publications@marquette Physician Assistant Studies Faculty Research and Publications Health Sciences, College of 8-12-2010 The P Wave: Indicator of Atrial Enlargement Patrick Loftis
More informationCongestive heart failure (CHF) is a. Diastolic Heart Failure. By Michel D Astous, MD, FRCPC
Diastolic Heart Failure The evaluation of both systolic and diastolic functions is of great importance among patients presenting with signs of CHF, as the treatment may be quite different depending on
More informationATRIAL FIBRILLATION: Scope of the Problem. October 2015
ATRIAL FIBRILLATION: Scope of the Problem October 2015 Purpose of the Presentation Review the worldwide incidence and prognosis associated with atrial fibrillation (AF) Identify the types of AF, clinical
More informationPress conference: Rheumatic Heart Disease a forgotten but devastating disease
www.worldcardiocongress.org Chairpersons: Bongani M. Mayosi Jonathan Carapetis Press conference: Rheumatic Heart Disease a forgotten but devastating disease www.worldcardiocongress.org www.worldcardiocongress.org
More informationAtherosclerosis of the aorta. Artur Evangelista
Atherosclerosis of the aorta Artur Evangelista Atherosclerosis of the aorta Diagnosis Classification Prevalence Risk factors Marker of generalized atherosclerosis Risk of embolism Therapy Diagnosis Atherosclerosis
More informationHeart Disease: Diagnosis & Treatment
How I Treat Cardiology Peer Reviewed Heart Disease: Diagnosis & Treatment Amara Estrada, DVM, DACVIM (Cardiology) University of Florida Background Clinical heart disease is the stage of disease when a
More informationCHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)
CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart
More informationJames F. Kravec, M.D., F.A.C.P
James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice
More informationCardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC
Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC The Federal Motor Carrier Safety Administration (FMCSA) administers the Federal Motor Carrier Safety Regulations (FMCSRs)
More informationCurriculum on Inpatient Cardiology Internal Medicine Residency Program Ochsner Clinic Foundation
Curriculum on Inpatient Cardiology Internal Medicine Residency Program Ochsner Clinic Foundation Authors: Bijesh Maroo MD David Elizardi MD, FACC Hector Ventura MD, FACC This document was created with
More informationTraumatic Cardiac Tamponade. Shane KF Seal 19 November 2003 POS
Traumatic Cardiac Tamponade Shane KF Seal 19 November 2003 POS Objectives Definition Pathophysiology Diagnosis Treatment Cardiac Tamponade The decompensated phase of cardiac compression resulting from
More informationHeart Sounds & Murmurs
Cardiovascular Physiology Heart Sounds & Murmurs Dr. Abeer A. Al-Masri MBBS, MSc, PhD Associate Professor Consultant Cardiovascular Physiologist Faculty of Medicine, KSU Detected over anterior chest wall
More informationEVALUATION OF MEDICAL RECORDS COMPLETENESS IN THE ADULT CARDIOLOGY CLINIC AT NORK MARASH MEDICAL CENTER
American University of Armenia Center for Health Services Research and Development Nork Marash Medical Center EVALUATION OF MEDICAL RECORDS COMPLETENESS IN THE ADULT CARDIOLOGY CLINIC AT NORK MARASH MEDICAL
More informationSurgeons Role in Atrial Fibrillation
Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)
More information1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA
1p36 and the Heart John Lynn Jefferies, MD, MPH, FACC, FAHA Director, Advanced Heart Failure and Cardiomyopathy Services Associate Professor, Pediatric Cardiology and Adult Cardiovascular Diseases Associate
More informationHEART DISEASE IN THE ELDERLY
CHAPTER 21 HEART DISEASE IN THE ELDERLY LAWRENCE H. YOUNG, M.D. INTRODUCTION The elderly represent the fastest-growing segment of the American population. By the year 2000, it is estimated that people
More informationDysfunction of aortic valve prostheses
Dysfunction of aortic valve prostheses Kai Andersen Oslo University Hospital Rikshospitalet, Norway Dysfunction of aortic valve prostheses Kai Andersen Oslo University Hospital Rikshospitalet, Norway No
More informationCOVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence
More informationPodcast with Dr. Kossick
Podcast with Dr. Kossick Interviewed by Western Carolina University Graduate Anesthesia Student Kristin Andrejco From the Head of the Bed main@fromtheheadofthebed.com December 5, 2014 (33 min) EKG Lead
More informationAcquired Heart Disease: Prevention and Treatment
Acquired Heart Disease: Prevention and Treatment Prevention and Treatment Sharon L. Roble, MD Assistant Professor Adult Congenital Heart Program The Ohio State University/Nationwide Children s Hospital
More informationDISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
More informationHeart Sounds and Murmurs. Objectives. Valves. Wright, 2012 1
Heart Sounds and Murmurs Wendy L. Wright, MS, RN, ARNP, FNP, FAANP Family Nurse Practitioner Owner Wright & Associates Family Healthcare Partner Partners in Healthcare Education 1 Objectives Upon completion
More informationAcute heart failure may be de novo or it may be a decompensation of chronic heart failure.
Management of Acute Left Ventricular Failure Acute left ventricular failure presents as pulmonary oedema due to increased pressure in the pulmonary capillaries. It is important to realise though that left
More information2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
More informationElectrocardiographic Issues in Williams Syndrome
Electrocardiographic Issues in Williams Syndrome R. Thomas Collins II, MD Assistant Professor, Pediatrics and Internal Medicine University of Arkansas for Medical Sciences Arkansas Children s Hospital
More informationThe Cardiac Society of Australia and New Zealand
The Cardiac Society of Australia and New Zealand Guidelines on Support Facilities for Coronary Angiography and Percutaneous Coronary Intervention (PCI) including Guidelines on the Performance of Procedures
More informationThoracoabdominal aortic aneurysm
Thoracoabdominal aortic aneurysm Patient (1) - 69 PMH: 2013 - MVP, aortic root replacement with biological valve (Perimount) and subtotal aortic arch replacement Analysis for oppressive chest complaints
More informationAtrial Fibrillation An update on diagnosis and management
Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.
More informationAdult Cardiac Surgery ICD9 to ICD10 Crosswalks
164.1 Malignant neoplasm of heart C38.0 Malignant neoplasm of heart 164.1 Malignant neoplasm of heart C45.2 Mesothelioma of pericardium 198.89 Secondary malignant neoplasm of other specified sites C79.89
More informationChapter 16. Learning Objectives. Learning Objectives 9/11/2012. Shock. Explain difference between compensated and uncompensated shock
Chapter 16 Shock Learning Objectives Explain difference between compensated and uncompensated shock Differentiate among 5 causes and types of shock: Hypovolemic Cardiogenic Neurogenic Septic Anaphylactic
More informationCARDIAC NURSING. Graduate Diploma in Nursing Science. Overview. Entry Requirements. Fees. Contact. Teaching Methods.
Graduate Diploma in Nursing Science CARDIAC NURSING Overview The Graduate Diploma in Nursing Science (Cardiac Nursing) is designed to develop advanced theoretical knowledge and specialist skills essential
More informationSECTION III: HEMODYNAMIC PRINCIPLES
10/5/00 3:36 PM 10 Calculation of Stenotic Valve Orifice Area Blase A. Carabello and William Grossman BAC: Baylor University, Department of Medicine, Houston Veterans Affairs Medical Center, Houston, Texas
More information